Back to results
US 2008/0167711 A1Published application
Device And Active Component For Inhibiting Formation Of Thrombus-Inflammatory Cell Matrix
AssigneeAdvanced Cardiovascular Systems, Inc.
InventorWouter E. Roorda
Life of this patent
Estimating the term…
Abstract
A combination drug treatment for inhibiting stenosis or restenosis is disclosed. The combination treatment is an active component containing both an anti-inflammatory substance and an anti-thrombotic substance which, together, contribute to an inhibiting effect on the initial stages of stenosis or restenosis. The active component can be delivered to a site of treatment by being carried on a device, such as a stent.
Claims9
A method of inhibiting restenosis, comprising:
- providing a device carrying an active component, the active component comprising at least one anti-thrombotic substance and at least one anti-inflammatory substance, wherein
- the anti-thrombotic substance(s) is/are not substantially released from the device and the anti-inflammatory substance(s) is/are;
- and,
- implanting the device in a blood vessel of a patient in need thereof.
1 more element
Dependencies are inferred from the claim text.